KIJIMEA

KIJIMEA Irritable Bowel Syndrome Capsules

Important notes (mandatory information)

Kijimea Irritable Bowel Capsules. Indications: for the treatment of irritable bowel syndrome with the typical symptoms of constipation, diarrhoea, abdominal pain, flatulence and bloating.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Kijimea Irritable Bowel Capsules

Please read all of this leaflet carefully because it contains important information for you. This medical device is available without a prescription. However, in order to achieve the best possible treatment success, Kijimea Irritable Bowel Capsules must be used as directed.

• Keep the package leaflet. You may want to read it again later.
• Ask your pharmacist if you need more information or advice.
• If your symptoms worsen or do not improve, you must see a doctor.

This package leaflet contains

1. WHAT ARE KIJIMEA IRRITABLE BOWEL CAPSULES AND WHAT ARE THEY USED FOR?
2. WHAT DO YOU NEED TO KNOW BEFORE TAKING KIJIMEA IRRITABLE BOWEL CAPSULES?
3. HOW TO TAKE KIJIMEA IRRITABLE BOWEL CAPSULES?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. HOW TO STORE KIJIMEA IRRITABLE BOWEL CAPSULES AND HOW LONG ARE THEY SHELF-LIFE?
6. FURTHER INFORMATION

1. WHAT ARE KIJIMEA IRRITABLE BOWEL CAPSULES AND WHAT ARE THEY USED FOR?

This medical device contains the bifido bacteria strain B.bifidum MIMBb75. It is used to treat irritable bowel syndrome with the typical symptoms of constipation, diarrhoea, abdominal pain, flatulence and bloating.

2. WHAT DO YOU NEED TO KNOW BEFORE TAKING KIJIMEA IRRITABLE BOWEL CAPSULES?

Kijimea Irritable Bowel Capsules contain no preservatives, sweeteners, flavourings, lactose or gluten and are also ideal for patients with diabetes.

During pregnancy and breastfeeding

There is no evidence to suggest that Kijimea Irritable Bowel Capsules should not be taken during pregnancy and breastfeeding.

In children

There is no evidence to suggest that Kijimea Irritable Bowel Capsules should not be taken by children and adolescents.

When taking Kijimea Irritable Bowel Capsules with medicines

Interactions with medicines are not known.

Other notes

If you experience new or persistent symptoms, you should see a doctor so that the cause of the symptoms and any underlying condition that may require treatment can be identified.

3. HOW TO TAKE KIJIMEA IRRITABLE BOWEL CAPSULES?

Always take Kijimea Irritable Bowel Capsules exactly as described in this leaflet. Please ask your doctor or pharmacist if you are not sure. The following information applies unless your doctor has prescribed Kijimea Irritable Bowel Capsules differently. Please follow the instructions for use, otherwise Kijimea Irritable Bowel Capsules will not work properly! Take two Kijimea Irritable Bowel capsules once a day with a meal, unchewed, with sufficient liquid (e.g. 1 glass of water). To achieve optimal results, Kijimea Irritable Bowel Capsules should be taken for at least four weeks, preferably twelve weeks. An initial relief of symptoms should be noticeable after about one week of regular use.

4. WHAT SIDE EFFECTS ARE POSSIBLE?

No side effects have been observed in connection with the use of Kijimea Irritable Bowel Capsules to date. If you notice any side effects, please inform the manufacturer stated in this leaflet.

5. HOW TO STORE KIJIMEA IRRITABLE BOWEL CAPSULES AND HOW LONG ARE THEY SHELF-LIFE?

Kijimea Irritable Bowel Capsules should be stored below 25°C and dry. Keep this product out of the reach of children. Do not use Kijimea Irritable Bowel Capsules after the expiry date stated on the outer carton.

6. FURTHER INFORMATION

Kijimea Irritable Bowel Capsules contain the bifido bacteria strain B.bifidum MIMBb75. The other ingredients are: corn starch, hypromellose, magnesium stearate, silicon dioxide, titanium dioxide, iron oxide, brilliant blue FCF.

Kijimea Irritable Bowel is available in packs of 14, 28 and 84 capsules.

Manufacturer/Distributor

Synformulas GmbH
Am Haag 14 o D-82166 Gräfelfing
D - Tel.: 0049 (0)89/7879790-78, Fax: 0049 (0)89/7879790-79, info@kijimea.de, www.kijimea.de
A - Tel.: 0043 (0)720/775404, Fax: 0043 (0)720/775559, info@kijimea.at, www.kijimea.at

This package leaflet was last revised in March 2017.

Source: Information from the package leaflet
Status: 10/2017
Indications: for the treatment of irritable bowel syndrome with the typical symptoms of constipation, diarrhoea, abdominal pain, flatulence and bloating.